In this week’s edition of InnovationRx, we look at biotech M&A, the rise of India’s Anthem Biosciences, and more.

In this week’s edition of InnovationRx, we look at biotech M&A, the rise of India’s Anthem Biosciences, and more.

With pharma and life sciences deal values surpassing $65 billion in Q1, marking the strongest quarter in the industry since 2020, analysts from PwC have declared that the…